Alnylam Pharmaceuticals (ALNY) Return on Capital Employed [ROCE] (2010 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Return on Capital Employed [ROCE] of 26.09% in Q2 2026, up 31.93 percentage points from -5.83% a year earlier and up 5.76 percentage points from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends
For FY2025, Alnylam Pharmaceuticals reported Return on Capital Employed [ROCE] of 15.99%, up 22.20 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has increased for three straight years, with a five-year change of +51.76 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -6.21% in FY2024 (+4.16 pp), -10.37% in FY2023 (+17.40 pp), -27.77% in FY2022 (-2.73 pp) and -25.05% in FY2021 (+10.73 pp).
- The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2010.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of +11.88 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 35.26 percentage points in Q2 2024, against a drop of 9.42 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 20.34% (Q1 2026), 14.57% (Q4 2025) and 8.39% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 20.76% |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 26.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.09% |
| Mar 31, 2026 | 20.34% |
| Dec 31, 2025 | 14.57% |
| Sep 30, 2025 | 8.39% |
| Jun 30, 2025 | -5.83% |
| Mar 31, 2025 | -3.66% |
| Dec 31, 2024 | -5.83% |
| Sep 30, 2024 | -6.52% |
| Jun 30, 2024 | 3.59% |
| Mar 31, 2024 | -6.09% |
| Dec 31, 2023 | -9.84% |
| Sep 30, 2023 | -13.27% |
| Jun 30, 2023 | -31.68% |
| Mar 31, 2023 | -28.19% |
| Dec 31, 2022 | -28.31% |
| Sep 30, 2022 | -29.74% |
| Jun 30, 2022 | -26.23% |
| Mar 31, 2022 | -22.82% |
| Dec 31, 2021 | -24.76% |
| Sep 30, 2021 | -24.59% |
API Access
Alnylam Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();